USD 2.69
(3.07%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -21.14 Million USD | -11.62% |
2022 | -18.71 Million USD | -27.16% |
2021 | -14.71 Million USD | -41.77% |
2020 | -10.38 Million USD | -5.75% |
2019 | -9.81 Million USD | -28.97% |
2018 | -7.61 Million USD | 7.54% |
2017 | -8.23 Million USD | -7.64% |
2016 | -7.64 Million USD | 47.2% |
2015 | -14.48 Million USD | 38.88% |
2014 | -23.69 Million USD | -57.22% |
2013 | -15.07 Million USD | 14.09% |
2012 | -17.54 Million USD | -27.8% |
2011 | -13.72 Million USD | -88611.55% |
2010 | -15.47 Thousand USD | -304.6% |
2009 | -3825.00 USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -8.26 Million USD | -11.41% |
2024 Q1 | -7.41 Million USD | -27.65% |
2023 Q1 | -4.38 Million USD | 11.24% |
2023 Q3 | -5.63 Million USD | -6.1% |
2023 Q4 | -5.8 Million USD | -3.0% |
2023 FY | -20.88 Million USD | -11.62% |
2023 Q2 | -5.31 Million USD | -21.32% |
2022 Q4 | -4.93 Million USD | -7.07% |
2022 Q1 | -4.48 Million USD | -14.12% |
2022 FY | -18.71 Million USD | -27.16% |
2022 Q2 | -4.68 Million USD | -4.35% |
2022 Q3 | -4.61 Million USD | 1.52% |
2021 Q2 | -3.44 Million USD | -3.8% |
2021 Q4 | -3.93 Million USD | 2.48% |
2021 FY | -14.71 Million USD | -41.77% |
2021 Q1 | -3.31 Million USD | 10.87% |
2021 Q3 | -4.03 Million USD | -17.18% |
2020 Q3 | -2.19 Million USD | 10.26% |
2020 FY | -10.38 Million USD | -5.75% |
2020 Q1 | -2.02 Million USD | 19.35% |
2020 Q2 | -2.44 Million USD | -21.03% |
2020 Q4 | -3.71 Million USD | -69.38% |
2019 Q3 | -1.99 Million USD | 8.52% |
2019 Q2 | -2.18 Million USD | 30.26% |
2019 Q1 | -3.13 Million USD | -41.89% |
2019 FY | -9.81 Million USD | -28.97% |
2019 Q4 | -2.5 Million USD | -25.49% |
2018 Q2 | -1.47 Million USD | 24.58% |
2018 Q4 | -2.2 Million USD | -11.47% |
2018 Q3 | -1.97 Million USD | -34.35% |
2018 FY | -7.61 Million USD | 7.54% |
2018 Q1 | -1.95 Million USD | -34.69% |
2017 Q3 | -2.08 Million USD | 9.11% |
2017 Q4 | -1.45 Million USD | 30.46% |
2017 FY | -8.23 Million USD | -7.64% |
2017 Q1 | -2.4 Million USD | -14.8% |
2017 Q2 | -2.29 Million USD | 4.58% |
2016 Q4 | -2.09 Million USD | -18.31% |
2016 FY | -7.64 Million USD | 47.2% |
2016 Q1 | -2.38 Million USD | 8.58% |
2016 Q3 | -1.77 Million USD | 1.67% |
2016 Q2 | -1.8 Million USD | 24.59% |
2015 FY | -14.48 Million USD | 38.88% |
2015 Q3 | -3.41 Million USD | 4.53% |
2015 Q4 | -2.61 Million USD | 23.45% |
2015 Q2 | -3.57 Million USD | 26.93% |
2015 Q1 | -4.89 Million USD | -9.96% |
2014 Q2 | -7.23 Million USD | -30.71% |
2014 Q3 | -6.48 Million USD | 10.42% |
2014 FY | -23.69 Million USD | -57.22% |
2014 Q1 | -5.53 Million USD | 0.0% |
2014 Q4 | -4.44 Million USD | 31.38% |
2013 Q2 | -4.21 Million USD | -31.27% |
2013 Q1 | -3.21 Million USD | 26.45% |
2013 FY | -15.07 Million USD | 14.09% |
2013 Q4 | - USD | 100.0% |
2013 Q3 | -3.88 Million USD | 7.83% |
2012 Q2 | -3.63 Million USD | -16.19% |
2012 Q1 | -3.12 Million USD | 62.05% |
2012 FY | -17.54 Million USD | -27.8% |
2012 Q4 | -4.36 Million USD | -33.07% |
2012 Q3 | -3.28 Million USD | 9.66% |
2011 Q1 | -1.17 Million USD | -44986.71% |
2011 FY | -13.72 Million USD | -88611.55% |
2011 Q4 | -8.23 Million USD | -283.12% |
2011 Q3 | -2.15 Million USD | 1.01% |
2011 Q2 | -2.17 Million USD | -85.64% |
2010 Q4 | -2595.00 USD | -151.9% |
2010 FY | -15.47 Thousand USD | -304.6% |
2010 Q3 | 5000.00 USD | 307.04% |
2010 Q2 | -2415.00 USD | 36.21% |
2010 Q1 | -3786.00 USD | -41.27% |
2009 Q1 | -100.00 USD | 0.0% |
2009 Q2 | -225.00 USD | -125.0% |
2009 Q3 | 6595.00 USD | 3031.11% |
2009 FY | -3825.00 USD | 0.0% |
2009 Q4 | -2680.00 USD | -140.64% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Acutus Medical, Inc. | -14.36 Million USD | -47.225% |
Cerus Corporation | -30.05 Million USD | 29.648% |
OrthoPediatrics Corp. | -25.76 Million USD | 17.942% |
PetVivo Holdings, Inc. | -10.62 Million USD | -99.062% |
Talis Biomedical Corporation | -66.81 Million USD | 68.356% |
Vivos Therapeutics, Inc. | -17.29 Million USD | -22.242% |
Inogen, Inc. | -109.38 Million USD | 80.671% |
Spectral AI, Inc. | -12.98 Million USD | -62.839% |
Nano-X Imaging Ltd. | -62.58 Million USD | 66.219% |
CVRx, Inc. | -43.1 Million USD | 50.948% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -499.291% |
Helius Medical Technologies, Inc. | -12.42 Million USD | -70.124% |
Orthofix Medical Inc. | -139.11 Million USD | 84.801% |
Venus Concept Inc. | -28.3 Million USD | 25.314% |
Accelerate Diagnostics, Inc. | -54.02 Million USD | 60.867% |
Bioventus Inc. | -81.72 Million USD | 74.129% |
BrainsWay Ltd. | -4.92 Million USD | -329.125% |
Envoy Medical, Inc. | -18.37 Million USD | -15.089% |
electroCore, Inc. | -18.8 Million USD | -12.433% |
IceCure Medical Ltd | -15.57 Million USD | -35.741% |
Lucid Diagnostics Inc. | -48.48 Million USD | 56.39% |
Monogram Orthopaedics, Inc. | -17.26 Million USD | -22.44% |
MaxCyte, Inc. | -48.29 Million USD | 56.225% |
NeuroOne Medical Technologies Corporation | -11.95 Million USD | -76.851% |
Nexalin Technology, Inc. | -5.69 Million USD | -271.171% |
PAVmed Inc | -68.79 Million USD | 69.267% |
Rapid Micro Biosystems, Inc. | -56.56 Million USD | 62.62% |
RxSight, Inc. | -50.08 Million USD | 57.786% |
Sight Sciences, Inc. | -57.27 Million USD | 63.084% |
SI-BONE, Inc. | -46.93 Million USD | 54.949% |
TELA Bio, Inc. | -44.07 Million USD | 52.029% |
TriSalus Life Sciences, Inc. | -54.15 Million USD | 60.955% |
Treace Medical Concepts, Inc. | -51.42 Million USD | 58.888% |
LivaNova PLC | -68.49 Million USD | 69.133% |
908 Devices Inc. | -42.75 Million USD | 50.552% |
Alphatec Holdings, Inc. | -173.39 Million USD | 87.806% |
Nemaura Medical Inc. | -9.59 Million USD | -120.349% |
NeuroPace, Inc. | -27.17 Million USD | 22.194% |
LENSAR, Inc. | -12.22 Million USD | -72.892% |
Apyx Medical Corporation | -17.25 Million USD | -22.504% |
Cutera, Inc. | -156.23 Million USD | 86.467% |
STRATA Skin Sciences, Inc. | -8.6 Million USD | -145.735% |
BioSig Technologies, Inc. | -28.51 Million USD | 25.845% |
Anika Therapeutics, Inc. | -87.63 Million USD | 75.875% |
ClearPoint Neuro, Inc. | -22.44 Million USD | 5.805% |
Integra LifeSciences Holdings Corporation | 111.52 Million USD | 118.958% |
Axonics, Inc. | -26.05 Million USD | 18.859% |
Outset Medical, Inc. | -169.77 Million USD | 87.546% |
IRIDEX Corporation | -10 Million USD | -111.282% |
PROCEPT BioRobotics Corporation | -109.17 Million USD | 80.633% |
IRadimed Corporation | 20.03 Million USD | 205.528% |
Tivic Health Systems, Inc. | -8.24 Million USD | -156.434% |
INVO Bioscience, Inc. | -6.76 Million USD | -212.436% |
Telesis Bio, Inc. | -35.15 Million USD | 39.849% |
Viemed Healthcare, Inc. | 14.33 Million USD | 247.544% |
Varex Imaging Corporation | 32.1 Million USD | 165.866% |
Quipt Home Medical Corp. | 3.91 Million USD | 639.5% |
Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -74.26% |
Pulmonx Corporation | -61.93 Million USD | 65.863% |
Dynatronics Corporation | -2.27 Million USD | -830.161% |
Modular Medical, Inc. | -17.52 Million USD | -20.617% |
ReShape Lifesciences Inc. | -14.63 Million USD | -44.429% |
Semler Scientific, Inc. | 22.25 Million USD | 194.999% |
InMode Ltd. | 195.66 Million USD | 110.806% |
Bruker Corporation | 436.9 Million USD | 104.839% |
Cytosorbents Corporation | -31.2 Million USD | 32.254% |
DexCom, Inc. | 597.7 Million USD | 103.537% |
Align Technology, Inc. | 643.33 Million USD | 103.286% |
Viveve Medical, Inc. | -21.55 Million USD | 1.902% |
ZimVie Inc. | -30.93 Million USD | 31.662% |
Movano Inc. | -29.69 Million USD | 28.787% |
Cytek Biosciences, Inc. | -27.84 Million USD | 24.069% |
Nexalin Technology, Inc. | -5.69 Million USD | -271.171% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -499.291% |
Tandem Diabetes Care, Inc. | -233.23 Million USD | 90.935% |
Profound Medical Corp. | -28.61 Million USD | 26.115% |
Insulet Corporation | 220 Million USD | 109.61% |
enVVeno Medical Corporation | -25.23 Million USD | 16.226% |
Surmodics, Inc. | -5.64 Million USD | -274.544% |
iCAD, Inc. | -7.68 Million USD | -174.977% |
Nuwellis, Inc. | -17.63 Million USD | -19.926% |
Biotricity, Inc. | -8.82 Million USD | -139.492% |
iRhythm Technologies, Inc. | -125.16 Million USD | 83.107% |
Aethlon Medical, Inc. | -12.63 Million USD | -67.316% |
PAVmed Inc. | -68.79 Million USD | 69.267% |
BIOLASE, Inc. | -17.93 Million USD | -17.874% |
Beyond Air, Inc. | -63 Million USD | 66.443% |
FONAR Corporation | 16.53 Million USD | 227.865% |
AxoGen, Inc. | -21.46 Million USD | 1.486% |
Vivani Medical, Inc. | -26.96 Million USD | 21.591% |
Tactile Systems Technology, Inc. | 18.04 Million USD | 217.194% |
Inari Medical, Inc. | -14.03 Million USD | -50.677% |
UFP Technologies, Inc. | 57.66 Million USD | 136.666% |
QT Imaging Holdings, Inc. | -4.92 Million USD | -329.073% |
Heart Test Laboratories, Inc. | -6.3 Million USD | -235.296% |
Tenon Medical, Inc. | -15.72 Million USD | -34.438% |
Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -182.887% |
Co-Diagnostics, Inc. | -42.7 Million USD | 50.492% |
AdaptHealth Corp. | -598.4 Million USD | 96.467% |
Sintx Technologies, Inc. | -13.35 Million USD | -58.28% |
NanoVibronix, Inc. | -3.43 Million USD | -515.338% |
Quanterix Corporation | -49.7 Million USD | 57.46% |
Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -74.26% |
Sensus Healthcare, Inc. | -382 Thousand USD | -5434.817% |
Pacific Biosciences of California, Inc. | -334.46 Million USD | 93.679% |
TransMedics Group, Inc. | -28.72 Million USD | 26.4% |
ReWalk Robotics Ltd. | -23.61 Million USD | 10.457% |
NeuroMetrix, Inc. | -7.15 Million USD | -195.643% |
Hyperfine, Inc. | -48.11 Million USD | 56.057% |
Establishment Labs Holdings Inc. | -65.02 Million USD | 67.485% |
Biomerica, Inc. | -6.36 Million USD | -232.072% |
Bone Biologics Corporation | -9.42 Million USD | -124.25% |
AVITA Medical, Inc. | -40.4 Million USD | 47.669% |
Bluejay Diagnostics, Inc. | -10.31 Million USD | -105.049% |
Silk Road Medical, Inc | -59.27 Million USD | 64.328% |